Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.
Mendra has raised $82.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Mendra's investors include 8VC, Lux Capital, Wing Venture Capital, 5AM Ventures, OrbiMed.
Mendra is headquartered in San Francisco, United States.
Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.
Mendra is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mendra — Funding & Investors." VCBacked, January 21, 2026, https://www.vcbacked.co/company/mendra. Accessed July 19, 2026.
VCBacked. (2026). Mendra — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/mendra
{{cite web |title=Mendra — Funding & Investors |url=https://www.vcbacked.co/company/mendra |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated